Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
Kchour G, Tarhini M, Kooshyar MM, El Hajj H, Wattel E, Mahmoudi M, Hatoum H, Rahimi H, Maleki M, Rafatpanah H, Rezaee SA, Yazdi MT, Shirdel A, de Thé H, Hermine O, Farid R, Bazarbachi A. Kchour G, et al. Among authors: kooshyar mm. Blood. 2009 Jun 25;113(26):6528-32. doi: 10.1182/blood-2009-03-211821. Epub 2009 May 1. Blood. 2009. PMID: 19411628 Free article. Clinical Trial.
Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
Kchour G, Makhoul NJ, Mahmoudi M, Kooshyar MM, Shirdel A, Rastin M, Rafatpanah H, Tarhini M, Zalloua PA, Hermine O, Farid R, Bazarbachi A. Kchour G, et al. Among authors: kooshyar mm. Leuk Lymphoma. 2007 Feb;48(2):330-6. doi: 10.1080/10428190601071717. Leuk Lymphoma. 2007. PMID: 17325893
The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
Kchour G, Rezaee R, Farid R, Ghantous A, Rafatpanah H, Tarhini M, Kooshyar MM, El Hajj H, Berry F, Mortada M, Nasser R, Shirdel A, Dassouki Z, Ezzedine M, Rahimi H, Ghavamzadeh A, de Thé H, Hermine O, Mahmoudi M, Bazarbachi A. Kchour G, et al. Among authors: kooshyar mm. Retrovirology. 2013 Aug 20;10:91. doi: 10.1186/1742-4690-10-91. Retrovirology. 2013. PMID: 23962110 Free PMC article.
Evaluating the Association between CCR5delta32 Polymorphism (rs333) and the Risk of Breast Cancer in a Cohort of Iranian Population.
Tajbakhsh A, Farjami Z, Nesaei-Bajestani A, Afzaljavan F, Rivandi M, Moezzi A, Abedini S, Asghari M, Kooshyar MM, Homaei Shandiz F, Pasdar A. Tajbakhsh A, et al. Among authors: kooshyar mm. Iran J Public Health. 2021 Mar;50(3):583-591. doi: 10.18502/ijph.v50i3.5604. Iran J Public Health. 2021. PMID: 34178806 Free PMC article.
Hereditary breast cancer; Genetic penetrance and current status with BRCA.
Mahdavi M, Nassiri M, Kooshyar MM, Vakili-Azghandi M, Avan A, Sandry R, Pillai S, Lam AK, Gopalan V. Mahdavi M, et al. Among authors: kooshyar mm. J Cell Physiol. 2019 May;234(5):5741-5750. doi: 10.1002/jcp.27464. Epub 2018 Dec 14. J Cell Physiol. 2019. PMID: 30552672 Review.
18 results